Tweedy Browne Co LLC's VRTX Position
VERTEX PHARMACEUTICALS — 10 quarters (Q4 2023 to Q4 2025)
Current Shares
39.1K
Current Value
$17.75M
Peak Shares
66.8K
Q4 2023
Overall Change
-41%
Shares Over Time
Q4 2023
66.8K
Q1 2024
66.7K
0%
Q2 2024
54.3K
-19%
Q3 2024
53.6K
-1%
Q4 2024
40.6K
-24%
Q1 2025
38.3K
-6%
Q2 2025
37.3K
-3%
Q3 2025
39.1K
+5%
Q3 2025
39.1K
0%
Q4 2025
39.1K
0%
Quarterly Detail
| Quarter | Shares | Value | $/Share | Change |
|---|---|---|---|---|
| Q4 2025 | 39.1K | $17.75M | $453.36 | 0% |
| Q3 2025 | 39.1K | $15.30M | $391.63 | 0% |
| Q3 2025 | 39.1K | $15.30M | $391.63 | +5% |
| Q2 2025 | 37.3K | $16.59B | $445200.01 | -3% |
| Q1 2025 | 38.3K | $18.58M | $484.81 | -6% |
| Q4 2024 | 40.6K | $16.36M | $402.70 | -24% |
| Q3 2024 | 53.6K | $24.93M | $465.07 | -1% |
| Q2 2024 | 54.3K | $25.47M | $468.72 | -19% |
| Q1 2024 | 66.7K | $27.88M | $418.01 | 0% |
| Q4 2023 | 66.8K | $27.17M | $406.90 | New |